Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
6.03
+0.09 (1.52%)
At close: Aug 11, 2026, 4:00 PM EDT
6.10
+0.07 (1.16%)
After-hours: Aug 11, 2026, 5:07 PM EDT

Strata Critical Medical Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Strata Critical Medical stock has a consensus rating of "Strong Buy" and an average price target of $9.56. The average 1-year stock price forecast is 58.54% higher than the current stock price, while the lowest is $8.00 (+32.67%) and the highest is $12.75 (+111.44%).

Price Target: $9.56 (+58.54%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$8.00$9.56$8.75$12.75
Change+32.67%+58.54%+45.11%+111.44%

Analyst Ratings

The average analyst rating for Strata Critical Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy444444
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total444444

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Lake Street
Lake Street
Buy
Reiterates
$9.5
BuyReiterates$9.5+57.55%Aug 3, 2026
Craig-Hallum
Craig-Hallum
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 26, 2026
Ladenburg Thalmann & Co.
Ladenburg Thalmann & Co.
Buy
Reiterates
$12
BuyReiterates$12+90.71%May 7, 2026
B. Riley Securities
B. Riley Securities
Buy
Initiates
$8
BuyInitiates$8+32.67%Mar 25, 2026

Financial Forecast

Revenue This Year
290.80M
from 197.14M
Increased by 47.51%
Revenue Next Year
326.10M
from 290.80M
Increased by 12.14%
EPS This Year
-0.14
EPS Next Year
-0.03
from -0.14
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
67.16M146.12M225.18M146.82M197.14M290.80M
Revenue Growth
32.92%117.58%54.11%-34.80%34.28%47.51%
Gross Profit
12.85M22.28M42.12M29.59M41.13M63.25M
Gross Margin
19.14%15.24%18.71%20.15%20.86%21.75%
Operating Income
-32.26M-50.50M-44.68M-21.11M-12.61M-6.75M
Net Income
-36.92M-27.26M-56.08M-27.31M41.35M-5.08M
EPS
------0.14
Free Cash Flow
--18.34M-11.67M-28.89M-26.98M19.00M
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High292.5M
Avg290.8M
Low289.1M

Revenue Growth

Revenue Growth202620272028
High
48.4%
Avg
47.5%
Low
46.6%

EPS Forecast

EPS202620272028
High-0.14
Avg-0.14
Low-0.14

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-